Vivesto AB (STO:VIVE)
Sweden · Delayed Price · Currency is SEK 0.0980
+0.0130 (15.29%)
At close: Feb 10, 2026
Vivesto AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
55.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 6.61M | 3.57M | 117.50% |
| Dec 31, 2022 | 3.04M | -25.83M | -89.47% |
| Dec 31, 2021 | 28.87M | 24.90M | 626.79% |
| Dec 31, 2020 | 3.97M | -202.23M | -98.07% |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EQL Pharma AB | 425.75M |
| Enzymatica AB | 52.73M |
| Cinclus Pharma Holding AB | 48.42M |
| Newbury Pharmaceuticals AB | 36.76M |
| Nanexa AB | 31.92M |
| Orexo AB | 26.00M |
| Moberg Pharma AB | 12.50M |
| Klaria Pharma Holding AB (publ.) | 10.05M |